Connect with us
Faes Farma is expanding its Vizcaya investment from €150 million to €200 million. The new Derio plant, ready to start in early 2025 pending Aemps authorization,...
Faes Farma forecasts a double-digit growth in Latin America and plans to expand its medical visit, animal nutrition, and health businesses. The Spanish pharmaceutical company aims...
Oryzon Genomics reduces losses by 20.7% in 2023, reporting over 3.3 million euros compared to the previous year's 4.2 million. Income falls by nearly 28%, standing...
Grifols and Pharma Mar reduced profits, while Reig Jofre, Faes Farma, Rovi and Almirall increased their profits between January and June. This last company has exceeded...
Rovi's increase was mainly driven by the strength of the third-party manufacturing business, which grew by 167%. Farma posted a net profit of $28 million (€26.6...
Faes Farma posted gross operating profit of $110.8 million (€95.1 million) through September. The pharma group ended the first nine months of 2021 with total revenues...
Grifols, which specializes in the production of plasma derivatives, achieved a profit of $317.2 million (€266.8 million) in the first half of 2021, which translates into...